Literature DB >> 8104796

Endogenous retroviral superantigen presentation by B cells induces the development of type 1 CD4+ T helper lymphocytes.

K J Gollob1, L Nagelkerken, R L Coffman.   

Abstract

The endogenous retroviral superantigen, minor lymphocyte stimulating antigen (Mls 1a, encoded by Mtv-7), when presented by highly purified B cells induced the development of a highly polarized population of T helper (Th)1 cells from naive peripheral CD4+ T cells in vitro. Immobilized anti-V beta 6 antibodies similarly generated highly polarized, largely V beta 6+, Th 1 populations in vitro. In the presence of exogenous interleukin-4, both stimuli were capable of generating Th 2, rather than Th 1 populations. Mls 1a presentation by B cells in vivo led to the development of an equally polarized Th 1 population. Using monoclonal antibodies against interferon-gamma and transforming growth factor-beta, it was demonstrated that maximal Th 1 development with either stimulus in vitro was dependent on the endogenous production of these two cytokines. Thus, our results demonstrate that the retroviral encoded superantigen, Mls 1a, drives the development of Th 1 cells both in vitro and in vivo, and they suggest that B cell presentation does not, in itself, lead to the generation of Th 2 cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104796     DOI: 10.1002/eji.1830231028

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  DBA/2J (Mls-1a) B-cell differentiation in BALB.xid recipients.

Authors:  K Tocce; K Suppiah; C Rago; R Liberchuk; K Duffy; J Riggs
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Peritoneal macrophages suppress T-cell activation by amino acid catabolism.

Authors:  R Matlack; K Yeh; L Rosini; D Gonzalez; J Taylor; D Silberman; A Pennello; J Riggs
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

3.  Increased serum IgG1 levels and reduced numbers of B-1 B cells in DBA/2J mice.

Authors:  K Tocce; G Masters; C Rago; L Prior; K Suppiah; T Glysing-Jensen; S Leary; J Riggs
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

4.  CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.

Authors:  J L Schultze; S Michalak; M J Seamon; G Dranoff; K Jung; J Daley; J C Delgado; J G Gribben; L M Nadler
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

5.  Genetics of graft-versus-host disease, I. A locus on chromosome 1 influences development of acute graft-versus-host disease in a major histocompatibility complex mismatched murine model.

Authors:  R D Allen; J A Dobkins; J M Harper; D L Slayback
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

6.  Tolerance to staphylococcal enterotoxin B initiated Th1 cell differentiation in mice infected with Candida albicans.

Authors:  L Romani; P Puccetti; A Mencacci; R Spaccapelo; E Cenci; L Tonnetti; F Bistoni
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

7.  Cytokine treatment of macrophage suppression of T cell activation.

Authors:  Daniel Silberman; Amanda Bucknum; Megan Kozlowski; Robin Matlack; James Riggs
Journal:  Immunobiology       Date:  2009-02-26       Impact factor: 3.144

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.